FDA clears Echosens FibroScan liver disease device

April 18, 2013 by Brad Perriello

Echosens wins FDA clearance for its FibroScan device for measuring liver function in patients with liver disease.

Echosens

French medical device maker Echosens said the FDA granted 510(k) clearance for its FibroScan device for evaluating liver function in patients with liver disease

The federal watchdog agency's nod marks the final major market approval for FibroScan, according to Echosens.

Paris-based Echosens said it introduced the FibroScan elastography device in Europe in 2003 and has since won approvals in 70 countries, including China, Canada, Brazil and Japan.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp